Drugs designed to treat diabetes have become one of the hottest and most controversial weight loss crazes.| New York Post
This cohort study investigates whether semaglutide prescription is associated with increased risk of nonarteritic anterior ischemic optic neuropathy among patients with type 2 diabetes and patients who are overweight or obese.| jamanetwork.com